MeSH note : sirolimus derivative from a biodegradable polylactic acid polymer; possesses enhanced
anti-inflammatory and antiproliferative activity with an improved pharmacokinetic
profile; structure in first source;
http://www.has-sante.fr/portail/jcms/c_1545470/fr/nobori-systeme-d-endoprothese-coronaire http://www.has-sante.fr/portail/jcms/c_1545469/fr/nobori-23-avril-2013-4396-avis 2013 France French CORONARY STENT, OTHER Drug-Eluting stents coronary artery disease health technology assessment sirolimus umirolimus treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1715363/fr/biomatrix http://www.has-sante.fr/portail/jcms/c_1716081/fr/biomatrix 2013 France French Drug-Eluting stents coronary artery disease health technology assessment sirolimus umirolimus ACTIVE CORONARY STENT treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1715362/fr/biomatrix-flex http://www.has-sante.fr/portail/jcms/c_1716084/fr/biomatrix-flex 2013 France French Drug-Eluting stents coronary artery disease sirolimus umirolimus health technology assessment ACTIVE CORONARY STENT treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_1216621/nobori-21-fevrier-2012-4217-avis http://www.has-sante.fr/portail/jcms/c_1231920/nobori-21-fevrier-2012-4217-avis 2012 France French ACTIVE CORONARY STENT coronary artery disease Drug-Eluting stents sirolimus umirolimus health technology assessment treatment outcome
--- http://www.has-sante.fr/portail/jcms/c_703389/nobori http://www.has-sante.fr/portail/jcms/c_703391/nobori-cepp-1784 2008 France French ACTIVE CORONARY STENT Drug-Eluting stents coronary artery disease sirolimus umirolimus health technology assessment treatment outcome